The original success of the copyright undeniably revolutionized the drug landscape, but betting in companies primarily reliant on generic versions presents a challenging picture. Although early earnings were substantial, the end of patents and the emergence of less expensive alternatives have diminished market share. Thus, a thorough evaluation … Read More